Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
Abstract
The present invention relates to a pharmaceutical composition or a composition for a medical device or a composition for a food supplement (briefly, the composition (s) of the present invention) based on lactic acid bacteria belonging to the species Lactobacillus fermentum for vaginal and oral use for the simultaneous treatment of vaginal infections, disorders or diseases of fungal and bacterial origin. Specifically, the present invention relates to a said composition comprising pharmaceutical- and/or food-grade excipients and a mixture, which comprises or, alternatively, consists of at least a strain of bacteria belonging to the species Lactobacillus fermentum for vaginal and oral use for the simultaneous treatment of vaginal infections, disorders or diseases selected from candidiasis, vaginitis, vulvovaginitis or bacterial vaginosis.
Claims
exact text as granted — not AI-modified1 . Pharmaceutical composition or composition for a medical device or composition for a food supplement or composition of a food product comprising pharmaceutical- and/or food-grade excipients and a mixture comprising or, alternatively, consisting of at least a strain of bacteria belonging to the species Lactobacillus fermentum ; said composition being for vaginal or oral use for the treatment of at least a vaginal infection, wherein said at least a vaginal infection comprises or consists of bacterial vaginosis, caused by the pathogenic bacterium Gardnerella vaginalis , wherein the bacteria of the species Lactobacillus fermentum belong to the strain (LF05) with deposit number DSM 32277 or CNCM I-789 (depositor Probiotical SpA).
2 . The composition for use according to claim 1 , wherein said mixture further comprises or, alternatively, consists of at least a strain of bacteria belonging to the species Lactobacillus fermentum selected from the group comprising or, alternatively, consisting of the strains of bacteria from 3 to 14 below:
List of tested strain
Abbreviation
ID
Deposit
Depositor
No. 3 L. fermentum
LF 06
1456
DSM 18295
Anidral Srl
No. 4 L. fermentum
LF 07
1459
DSM 18296
Anidral Srl
No. 5 L. fermentum
LF 08
1460
DSM 18297
Anidral Srl
No. 6 L. fermentum
LF 09
1462
DSM 18298
Anidral Srl
No. 7 L. fermentum
LF 10
1637
DSM 19187
Anidral Srl
No. 8 L. fermentum
LF 11
1639
DSM 19188
Anidral Srl
No. 9 L. fermentum
DPPMA 114
1757
DSMZ 23757
Probiotical SpA
No. 10 L. fermentum
Lb2
1753
DSM 16143
Probiotical SpA
No. 11 L. fermentum
LF 15
1852
DSM 26955
Probiotical SpA
No. 12 L. fermentum
LF16
1853
DSM 26956
Probiotical SpA
No. 13 L. fermentum
LF18
1897
DSM 29197
Probiotical SpA
No. 14 L. fermentum
LF 25
1956
DSM 32275
Probiotical SpA
3 . The composition for use according to claim 2 , wherein said mixture comprising or, alternatively, consisting of at least a strain of bacteria belonging to the species Lactobacillus fermentum selected from the group comprising or, alternatively, consisting of the strains of bacteria No. 7, 8, 11, 12, 13 and 14.
4 . The composition for use according to claim 3 , wherein said mixture comprising or, alternatively, consisting of at least a strain of bacteria belonging to the species Lactobacillus fermentum selected from the group comprising or, alternatively, consisting of the strains of bacteria No. 8, 11, 13 and 14.
5 . The composition for use according to claim 1 , wherein said vaginal infection further comprises a vaginal infection, vaginitis, vulvovaginitis o bacterial vaginosis due to at least a pathogen selected from the group comprising: Candida albicans, Candida glabrata, Candida parapsilosis, Candida krusei, Candida tropicalis, Trichomonas vaginalis, Neisseria gonorrhoeae, Escherichia coli , Herpes simplex and Hemophilus ducreyi.
6 . The composition for use according to claim 1 , wherein said composition is for the treatment of a vaginal infection, disorder or disease caused by the pathogens Candida albicans and Gardnerella vaginalis.
7 . The composition for use according to claim 1 , wherein said composition is in a solid form or liquid form, preferably is in the form of powder, granules, tablet, lozenge, solution, vaginal douche, dispersion or gel.
8 . The composition for use according to claim 1 , wherein said mixture contains said strains of bacteria at a concentration comprised from 1×10 8 to 1×10 12 CFU/g, preferably from 1×10 9 to 1×10 11 CFU/g.
9 . The composition for use according to claim 1 , wherein said composition contains said strains of bacteria at a concentration comprised from 1×10 6 to 1×10 10 CFU/g, preferably from 1×10 7 to 1×10 9 CFU/g.
10 . The composition for use according to claim 1 , wherein said mixture of bacteria in present in said composition in a weight ratio comprised from 1:2 to 1:10, preferably in a weight ratio comprised from 1:3 to 1:5.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.